Molecular formula: | C23H19N3O2 |
Average mass: | 369.424 |
Monoisotopic mass: | 369.147727 |
ChemSpider ID: | 9669218 |
2 of 2 defined stereocentres
Wikipedia
(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]chinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidindion
[German]
[ACD/IUPAC Name](3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]chinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidin-2,5-dion
(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoléin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione
[French]
[ACD/IUPAC Name](3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione
[ACD/IUPAC Name](3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-
[ACD/Index Name]905854-02-6
[RN]PJ4H73IL17
[UNII]Tivantinib
[Spanish]
[INN]Tivantinib
[French]
[INN]Tivantinibum
[Latin]
[INN](3R,4R)-3-(2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
(3R,4R)-3-(5,6-dihydro-4h-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1h-indol-3-yl)pyrrolidine-2,5-dione
(−)-3(R),4(R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione
905853-99-8
[RN]ARQ-197::Tivantinib
Hepatocyte growth factor receptor
MET_HUMAN
MFCD11977597
[MDL number]TIV
tivantinibum
тивантиниб
[Russian]تيفانتينيب
[Arabic]